OncoPrecision

New York, NY · Founded 2020 · Privately Held (backing)

Developer of a patient micro avatar platform designed to get the cancer therapy to the right patient. OncoPrecision is based in New York, NY and was founded in 2020. Its last reported valuation was $18 million in Oct 2025. It has raised $8.7 million.

Last reported valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$8.7M
Last round
—

Who backs OncoPrecision?

8 investors
InvestorType
SOSVVenture capital
Endless Frontier Labs—
IndieBioOther
New York VenturesVenture capital
Creative VenturesVenture capital
Grid ExponentialOther
AIR Capital—
Fundación Para el Progreso de la Medicina—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

OncoPrecision investors

8 investors are on record for OncoPrecision, including SOSV, Endless Frontier Labs, IndieBio and New York Ventures.

Free account
More of OncoPrecision with a free account
  • ·Watch OncoPrecision: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like OncoPrecision. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View